...We Welcome You To The Resverlogix HUB On AGORACOM!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Eastern exercised some $0.90 cent warrants

By my math the 13,270,000 and 5,600,000 units HL and Eastern subscribed to respectively, they translate into 18,870,000 units with the warrants totalling a little over 1.4 million....and being priced at $2.67 for net proceeds of close to $3.8 million if converted...

Not a huge sum given the burn rate....but the money they just got from Eastern's conversion is probably enough for Rothschild's retainer anyway. Every little bit helps at this stage until something more substantial can be arranged, hopefully at significantly higher prices than $3 or $4  per share...

Now its time for bed.....does anyone sleep in this hub?

Share
New Message
Please login to post a reply